Boosting levels of the neurotransmitter norepinephrine with atomoxetine, a repurposed ADHD medication, may be able to stall neurodegeneration in people with early signs of Alzheimer's disease, a study conducted at Emory Brain Health Center suggests.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
0 Response to "Study points toward an alternative drug strategy to stall Alzheimer’s neurodegeneration"
Post a Comment